Private doctors’ protest near Suvarna Soudha enters fourth day

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Mysuru, Feb 29: Tension prevailed at Tandavaput Industrial Area in Nanjangud taluk, Mysuru when a paper factory received a bomb threat call, which later turned out to be a hoax call.

The police said that the authorities of Rajshil Papers received a bomb threat call in the morning. After getting the information, the bomb detection squad rushed to the spot and inspected the factory premises and declared that it was a hoax call.

According to the police, an unidentified person called from his mobile, which is now switched off.

Newsroom, Jul 15: At least three students have committed suicide in different parts of Karnataka after failing in II PUC examinations, the results of which were announced yesterday. 

Bhumika, an 18-year-old girl hailing from Mallipattene near Arakalagud town in Hassan district killed herself within hours after the announcement of results. 

Depressed over her failure in the examination, she consumed poison, the police sources said. 

In a separate incident, 18-year-old Chitra, who failed the II PUC examinations, committed suicide at her native Chikkamarasa village in Shivamogga district. 

She was studying in Government PU College in Kumsi and after knowing about her result in the final PU exam, she hanged herself to death at her house.

Similarly, an 18-year-old boy from Harihar taluk in Davanagere district committed suicide in his house after the announcement of the PUC results.